Crozer-Keystone Enters Into Agreement with New York Blood Center
CKHS Hospital Laboratories recently announced that the health system entered into an exclusive blood supply agreement with New York Blood Center. Previously, Crozer-Chester Medical Center utilized New York Blood Center exclusively, while other CKHS hospitals used a combination of American Red Cross and New York Blood Center. The conversion to New York Blood Center became effective on Sept. 22.
For more than 40 years, New York Blood Center has provided their community with the highest quality transfusion products and services, as well as leading-edge research, technological and medical care innovation and education in the field of transfusion medicine. The organization provides blood products and clinical and transfusion services to close to 200 hospitals in New York, New Jersey and Pennsylvania.
Employees can expect:
- No changes to the volume of the health system’s on-site blood inventory.
- The same product types available to patients.
- The same turnaround times for blood and blood products.
- A 100 percent back-up inventory to be maintained at Crozer.
- The same CKHS transfusion tags.
- Blood drives to support our communities’ urgent need for blood and blood products.
A minor change clinical staff members need to be aware of:
- Random donor platelets are being eliminated. All platelet product requests will be filled with leukoreduced pheresis platelets which provide a larger dose of platelets to boost the patient’s platelet count more efficiently.
For more information, contact the CKHS Laboratories representative at your hospital site.